Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026)
Jushi Holdings (JUSHF) reported Cash from Investing Activities of -$4.1 million for Q1 2026, up 6.74% year-over-year from -$3.8 million in Q1 2025, and down 32.9% quarter-over-quarter from -$3.1 million in Q4 2025.
Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash from Investing Activities data on file, last reported at -$4.1 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$4.1 million, up 6.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.9 million (down 20.82% YoY), and the FY2025 annual result was -$13.2 million, down 87.09% from the prior year.
- Cash from Investing Activities retreated to -$4.1 million in Q1 2026 per JUSHF's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $1.7 million in Q2 2024 and troughed at -$38.1 million in Q2 2022.
- A 5-year average of -$6.6 million and a median of -$4.1 million in 2026 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 348.1% in 2024 and fell as far as 2112.2% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$7.7 million in 2022, then jumped by 95.76% to -$328000.0 in 2023, then tumbled by 2112.2% to -$7.3 million in 2024, then surged by 57.69% to -$3.1 million in 2025, then slumped by 32.9% to -$4.1 million in 2026.
- Business Quant data shows JUSHF's Cash from Investing Activities at -$4.1 million in Q1 2026, -$3.1 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.08 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | -5.32 Mn |
| Sep 30, 2025 | -5.32 Mn |
| Jun 30, 2025 | -459,000.00 |
| Jun 30, 2025 | -459,000.00 |
| Mar 31, 2025 | -4.38 Mn |
| Mar 31, 2025 | -4.38 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Sep 30, 2024 | -770,000.00 |
| Sep 30, 2024 | -770,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -743,000.00 |
| Mar 31, 2024 | -743,000.00 |
| Dec 31, 2023 | -328,000.00 |
| Dec 31, 2023 | -328,000.00 |